Reports estimate that one-third of the patients who receive biologic medicines experience primary failure to their treatment, and up to 60% of those who respond initially suffer a loss of response over time.To maximize success of these therapeutic strategies, it is important to monitor drug levels with therapeutic drug monitoring. These scientific topics will explore the benefits and methods of TDM.

References

1. Source: Papamichael K, Cheifetz AS. Use of anti-TNF drug levels to optimise patient management. Frontline Gastroenterol. 2016; 7:289-300.  PUBMED link